Literature DB >> 11847507

Relation of apolipoprotein (a) phenotypes to diabetic retinopathy in elderly type 2 diabetes.

Tatsuya Suzuki1, Kenzo Oba, Yoshimasa Igari, Noriaki Matsumura, Yuki Inuzuka, Yoshiaki Kigawa, Yoshiki Matsuura, Yumiko Ajiro, Kyoji Okazaki, Hiroshi Nakano.   

Abstract

The aim of this study was to clarify the relationship between apolipoprotein (a) (apo (a) ) phenotypes and diabetic retinopathy in elderly type 2 diabetes. Serum Lp (a) concentrations and apo (a) phenotypes were analyzed in 250 diabetic patients aged 60 to 88 years old. Apo (a) phenotypes were classified into 7 subtypes (F, B, S1, S2, S3, S4, O (Null) ) by the method SDS electrophoresis with Western blotting. Patients were divided into two groups according to their apo (a) phenotypes:a low molecular weight (LMW) Lp (a) group, and a high molecular weight (HML) Lp (a) group. Patients were classified as having one of 4 types of diabetic retinopathy: no retinopathy (R0), simple retinopathy (R1), pre-proliferative retinopathy (R2), and proliferative retinopathy (R3). There was a significant association between serum Lp (a) levels and severity of diabetic retinopathy (p<0.001). A gradual trend toward increasing serum Lp (a) levels was observed across the groups (from R0 to R3). A significantly greater percentage of LMW Lp (a) was observed in the R1, R2, and R3 groups than in the R0 group (42.9% (p<0.001), 27.0% (p<0.01), and 27.3% (p<0.05) vs. 10.4%). Multiple logistic regression analysis revealed that duration of diabetes and LMW Lp (a) are independent risk factors for diabetic retinopathy. These results provide significant evidence that LMW Lp (a) contributes to an increased risk of diabetic retinopathy in elderly type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11847507     DOI: 10.1272/jnms.69.31

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  3 in total

1.  Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.

Authors:  Shigeki Nagamachi; Seigo Fujita; Ryuichi Nishii; Shigemi Futami; Shozo Tamura; Masanari Mizuta; Masamitsu Nakazato; Takeshi Kurose; Hideyuki Wakamatsu
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

2.  Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease.

Authors:  Tatsuya Suzuki; Shoko Futami-Suda; Yoshimasa Igari; Kentaro Watanabe; Motoshi Ouchi; Kazunari Suzuki; Ken-Ichi Sekimizu; Yoshiaki Kigawa; Hiroshi Nakano; Kenzo Oba
Journal:  Lipids Health Dis       Date:  2013-03-07       Impact factor: 3.876

3.  Overexpression of nuclear transport factor 2 may protect against diabetic retinopathy.

Authors:  Bin Li; Hai-Qing Zhang; Yu Shi; Yun-Bing Min; Shao-Fen Lin; Kai-Li Wu; Jie Hu; Shi-Bo Tang
Journal:  Mol Vis       Date:  2009-04-27       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.